acetaminophen 110 MG / aspirin 162 MG / caffeine 32.4 MG / salicylamide 152 MG Oral Tablet [Exaprin]
RxNorm concept 1358853, branded drug (sbd). Prescribable name: EXAPRIN Extra-Strength Pain Reliever 110 MG / 162 MG / 32.4 MG / 152 MG Oral Tablet.
- RxCUI
- 1358853
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1358853 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
APAP 110 MG / ASA 162 MG / Caffeine 32.4 MG / salicylamide 152 MG Oral Tablet [Exaprin]; Exaprin (APAP 110 MG / ASA 162 MG / caffeine 32.4 MG / salicylamide 152 MG) Oral Tablet
Related concepts
- aspirin 162 MG (SCDC, consists of)
- caffeine 32.4 MG (SCDC, consists of)
- acetaminophen 110 MG (SCDC, consists of)
- salicylamide 152 MG (SCDC, consists of)
- acetaminophen 110 MG / aspirin 162 MG / caffeine 32.4 MG / salicylamide 152 MG [Exaprin] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Exaprin (BN, has ingredient)
- acetaminophen 110 MG / aspirin 162 MG / caffeine 32.4 MG / salicylamide 152 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 50332010504
- 50332010507
- 50332010508
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1358853 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1358853 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1358853. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.